News
November Research Group (www.novemberresearch.com), a global leader of professional services providing drug and medical device safety consulting and software solutions for pharmaceutical and life sciences organizations, will exhibit at the 11th Annual DIA Conference on Pharmacovigilance and Risk Management Strategies, January 23-25, in Arlington, VA.
November Research will have staff onsite to share their expertise, focusing on their innovative Oracle Argus Safety Suite best practices methodology for implementations, upgrades and migrations from the Oracle AERS and Clintrace systems. November Research welcomes all attendees to visit their booth during the event to discuss how their services can help companies with their Pharmacovigilance and Drug Safety System services needs.
To arrange a personal meeting with November Research Group executives, please contact Vice President of Sales and Marketing, Susan Jalbert, at 910-233-6048 or email susan@novemberresearch.com.
November Research Group is a professional services firm specializing in pharmacovigilance solutions. We offer a full range of consulting services and software to optimize your adverse event reporting and risk management processes. For more details on how we can help you, please visit our website atNovemberResearch.com.
San Francisco, CA – June 14, 2011 – November Research Group, LLC (www.novemberresearch.com), a professional services firm that provides drug and medical device safety consulting and software solutions for pharmaceutical and life sciences organizations, announced today that it has achieved the Oracle PartnerNetwork (OPN) Specialization in the Oracle Argus Safety Suite. Already a Gold level partner within OPN, the Oracle Argus Safety Suite Specialization recognizes November Research Group’s ability to offer its clients expert and specialized solutions and services based on the industry’s leading safety and pharmacovigilance software.
“Achieving Specialization in the Oracle Argus Safety Suite is a significant milestone for November Research Group, and we are thankful for the recognition by Oracle, as well as our clients, of our expertise and commitment to Oracle Argus and the area of medical product safety,” said Seth Warhaftig, Founder and Chief Executive Officer, November Research Group.
"November Research Group is a long-standing member of the Oracle PartnerNetwork with a focus on Oracle Health Sciences solutions ," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "With its OPN Specialization in Oracle Argus Safety Suite, November Research Group's consultants have demonstrated expertise in Oracle Argus Safety Suite deployments, and can help customers accelerate implementation and maximize the value of Oracle Health Sciences software."
About Oracle PartnerNetwork
Oracle PartnerNetwork (OPN) Specialized is the latest version of Oracle's partner program that provides partners with tools to better develop, sell and implement Oracle solutions. OPN Specialized offers resources to train and support specialized knowledge of Oracle products and solutions and has evolved to recognize Oracle's growing product portfolio, partner base and business opportunities. Key to the latest enhancements to OPN is the ability for partners to differentiate through Specializations. Specializations are achieved through competency development, business results, expertise and proven success. To find out more visit http://www.oracle.com/partners.
About November Research Group
November Research Group is a professional services firm that provides a complete spectrum of software and services to the pharmacovigilance departments in the biopharmaceutical industry, with extensive expertise in: implementation and support for the Oracle Argus Safety Suite, Oracle AERS, and other commercial adverse event reporting systems; requirements specification and system selection; custom software application and tool development, and software validation. In addition, November Research Group provides the PRIMO application for companies to enable a streamlined and rapid data intake for adverse event cases from all sources.
Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates.
Contact
marketing@novemberresearch.com
November Research Group is looking for individuals who have solid consulting and technical skills with experience in the pharmaceutical and biotechnology industries. Candidates will primarily work in project teams at pharmaceutical and biotech companies to implement and support the client's implementation and use of their pharmacovigilance system.
November Research Group will have an exhibit booth at the 2011 Annual DIA in Chicago from June 19th to June 23rd. Please stop by the booth to learn about our Oracle Argus Specialized practice, get a demonstration of PRIMO, or hear about other ways we can help you establish a world class pharmacovigilance information architecture.
November Research Group is pleased to announce the general availability of PRIMO, our new, streamlined data capture system for adverse events, pregnancy registry, and product complaints. PRIMO complements and extends your existing pharmacovigilance system by providing a unified data intake mechanism from your call centers, safety data management organizations, affiliates and partners. For more information, download the PRIMO datasheet or request a demo by clicking here:PRIMO Demo
Custom Web Design